Swiss Re’s Thermo Fisher Scientific TMO Stock Holding History

Swiss Re’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$343K	Buy	685 +637	+1,327%	+$306K	0.03%	61
2026 Q1	$23.6K	Hold	48	–	–	0.14%	105
2025 Q4	$27.8K	Buy	+48	New	+$27.1K	﹤0.01%	84

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Swiss Re's TMO Position: Q2 2026 in Review

Swiss Re increased its Thermo Fisher Scientific (TMO) stake by 1,327% in Q2 2026, buying an estimated $306K and bringing the position to 685 shares worth $343K. The position accounts for 0.03% of the portfolio, ranked #61.

Swiss Re first reported a position in TMO in Q4 2025 and has held it in 3 quarters since. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Swiss Re held 685 shares of Thermo Fisher Scientific worth $343K as of Q2 2026.
Swiss Re bought 637 Thermo Fisher Scientific shares in Q2 2026, an estimated $306K.
Thermo Fisher Scientific made up 0.03% of Swiss Re's portfolio in Q2 2026, its #61 holding.
Swiss Re first reported a position in Thermo Fisher Scientific in Q4 2025 and has held it in 3 quarters since.
2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Swiss Re's 13F filing for Q2 2026, filed 11 Aug 2026.